Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Manufacturer Patient Assistance Programs To Change Following IG Guidance

Executive Summary

An HHS Office of Inspector General "1special advisory bulletin" on manufacturer-sponsored patient assistance programs for Medicare Part D beneficiaries will force companies to restructure these programs

You may also be interested in...



Drug Assistance Programs Show Tightening Government Safeguards

HHS Office of Inspector General releases flurry of advisories on patient assistance programs for outpatient drugs.

Crohn’s/Colitis Drug Copay Assistance For Medicare, Medicaid Enrollees Cleared By OIG

The HHS Office of Inspector General concludes a charitable organization’s proposed copay assistance program for patients with Crohn’s disease and ulcerative colitis may be offered to enrollees in Medicare and Medicaid without violating federal anti-kickback laws.

OIG OKs Financial Assistance Program For Genetic Tests

A charitable foundation's plan to help patients pay for genetic testing for cancer screening or diagnosis will not violate federal anti-kickback laws, the HHS Office of Inspector General said.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046560

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel